In the Media
Are you looking for the latest media coverage of the BioMed X Institute, its research projects and people behind the innovation model? Here you will find the latest clippings – hot off the press!
Visit: Global Roundup: BioMed X, Merck KGaA Expand Oncology Collaboration
Global Roundup: BioMed X, Merck KGaA Expand Oncology Collaboration
BioSpace
Germany-based BioMed X Institute expanded its collaboration with Merck KGaA, Darmstadt, Germany to include a total of eight research programs in the field of DNA damage response and RNA splicing.
Visit: BioMed X expands research partnership with Merck KGaA
BioMed X expands research partnership with Merck KGaA
Pharmaceutical Commerce
BioMed X, an independent research institute, revealed the start of its eighth joint research program with Merck KGaA, Darmstadt, Germany. The new program will dive into the role of extrachromosomal DNA in cancer and it will complement the research of two ongoing oncology programs at BioMed X in the fields of DNA damage response and RNA splicing.
Visit: BioMed X Expands Collaboration with Merck
BioMed X Expands Collaboration with Merck
Contract Pharma
BioMed X, an independent research institute, has initiated its eighth joint research program with Merck KGaA, Darmstadt, Germany.
Visit: BioMed X and Merck launch new Oncology research programme
BioMed X and Merck launch new Oncology research programme
Pharmafile
BioMed X and Merck have launched a new joint research programme in oncology.
Visit: Merck KGaA and BioMed X launch new joint cancer research programme
Merck KGaA and BioMed X launch new joint cancer research programme
PharmaTimes online
German pharma company Merck KGaA has announced a new partnership with BioMed X, an independent research institute located at the University of Heidelberg in Germany, in the area of oncology.
Visit: BioMed X and Merck launch oncology research programme
BioMed X and Merck launch oncology research programme
Manufacturing Chemist
The key aim of the project will be to generate a comprehensive atlas of extrachromosomal DNA in human cancer tissues.
Visit: BioMed X and Merck KGaA, Darmstadt, Germany launch new research program in oncology
BioMed X and Merck KGaA, Darmstadt, Germany launch new research program in oncology
1st Oncology
On July 5, 2021 BioMed X, a leading independent research institute, reported the start of its eighth joint research program with Merck KGaA, Darmstadt, Germany.